NCT01278394View on ClinicalTrials.gov

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Onychomycosis
Interventions
DRUG

AN2690 Solution, 5.0%

Once daily application for 360 days

Trial Locations (2)

Unknown

Instituto Dermatologico Jalisciense, Guadalajara

IMIC, Mexico City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01278394 - Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail | Biotech Hunter | Biotech Hunter